Precision Medicine and the Convergence of Science and Technology

I am a firm believer in the potential of combining life sciences with the latest technological advancements. At Biotechnology Group Inc. (2008–2014), we focused on DNA testing and analysis, process automation for creating genetic profiles, and comprehensive human genetic research.

Under my leadership, successful genetic testing projects were initiated in Ukraine, Russia, and the Baltic countries. In collaboration with Harvard Medical School and Stanford Biomath, I played a crucial role in developing easily understandable genetic reports for both doctors and patients.

Digital Invest Inc., founded in 2021, focuses on bio-mathematical medicine — applying science, DNA technologies, AI, and ML to clinical and research workflows. Featured in Healthcare Tech Outlook (2023).

Digital Invest advances bio-mathematical medicine through projects including Human Digital Model and BioMath Life. In 2026, Michael Kofman founded AGRON Inc. to lead the Aerial-Ground Robotics Operations Network — UAV capability development, geospatial systems, and maritime intelligence at agron1.com.